Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period

Virology

Volumn 301, Issue 1, 2002, Pages 148-156

  Wittke, V ^a   Robb, T E ^a   Thu, H M ^a   Nisalak, A ^b   Nimmannitya, S ^b   Kalayanrooj, S ^b   Vaughn, D W ^c   Endy, T P ^c   Holmes, E C ^d   Aaskov, J G ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b QUEEN SIRIKIT NATIONAL INSTITUTE OF CHILD HEALTH   (Thailand)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Dengue virus; Evolution; Thailand

Indexed keywords

NUCLEOTIDE; PROTEIN E; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL LINEAGE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; EPIDEMIC; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; THAILAND; VIRUS STRAIN;

DENGUE VIRUS; DENGUE VIRUS TYPE 3;

EID: 0036395194     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1549     Document Type: Article

References (38)

1. Aaskov, J. G., Geysen, H. M., and Mason, T. J. (1989). Serologically defined linear epitopes in the envelope protein of dengue 2 (Jamaica strain 1409). Arch. Virol. 105, 209-221.
2. Bhamarapravati, N., and Yoksan, S. (1997). Live attenuated dengue vaccine. In "Dengue and Dengue Haemorrhagic Fever." pp. 367-378. CAB International, New York.
3. Bray, M., Men, R., Tokimatsu, I., and Lai, C.-J. (1998). Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence. J. Virol. 72, 1647-1651.
4. Chungue, E., Cassar, O., Drouet, M. T., Guzman, M. G., Laille, M., Rosen, L., and Deubel, V. (1995). Molecular epidemiology of dengue 1 and dengue 4 viruses. J. Gen. Virol. 76, 1877-1884.
5. Crill, W. D., and Roehrig, J. T. (2001). Monoclonal antibodiesthat bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75, 7769-7773.
6. Duarte, E., Novella, I. S., Ledesma, S., Clarke, S., Moya, A., Elena, S. F., Domingo, E., and Holland, J. J. (1994). Subclonal components of consensus fitness in an RNA virus clone. J. Virol. 68, 4295-4301.
7. Escarmis, C., Davila, M., Charpentier, N., Bracho, A., Moya, A., and Domingo, E. (1996). Genetic lesions associated with Muller's Ratchet in an RNA virus. J. Mol. Biol. 264, 255-267.
8. Gubler, D. J. (1998). Dengue and dengue haemorrhagic fever. Clin. Microbiol. Rev. 11, 480-496.
9. Gubler, D. J., and Meltzer, M. (1999). Impact of dengue/dengue haemorrhagic fever on the developing world. Adv. Virus Res. 53, 35-70.
10. Gubler, D. J., Nalim, S., Tan, R., Saipan, H., and Sulianti-Saroso, J. (1979). Variation ni susceptibility to oral infection with dengue viruses amng geographic strains of Aedes aegypti. Am. J. Trop. Med. Hyg. 28, 1045-1052.
11. Guirakhoo, F., Hunt, A. R., Lewis, J. G., and Roehrig, J. T. (1993). Selection and partial characterisation of dengue 2 virus mutants that induce fuson at elevated pH. Virol. 194, 219-223.
12. Gulano, R. C., Pryor, M. J., Cauchi, M. R., Wright, P. J., and Davidson, A. D. (1998). Identification of a major determinant of mouse neuro-virulence of dengue type 2 virus using stably cloned genomic length cDNA. J. Gen. Virol. 79, 437-446.
13. Hanna, J. N., Ritchie, S. A., Phillips D. A., Serafin, I. L., Hills, S. L., van den Hurk, A. F., Pyke, A. T., McBride, W. J. H., Amadio, M. G., and Spark, R. L. (2001). An epidemic of dengue 3 in far north Queensland, 1997-1999. Med. J. Aust. 174, 178-182.
14. Innis, B. L., Thirawuth, V., and Hemachuda, C. (1989). Identification of continuous epitopes of the envelope glycoprotein of dengue type 2 virus. Am. J. Trop. Med. Hyg. 40, 676-687.
15. Lanciotti, R. S., Gubler, D. J., and Trent, D. W. (1997). Molecular evolution and phylogeny of dengue 4 viruses. J. Gen. Virol. 78, 2279-2286.
16. Lanciotti, R. S., Lewis, J. G., Gubler, D. J., and Trent, D. W. (1994). Molecular evolution and epidemiology of dengue 3 viruses. J. Gen. Virol. 75, 65-75.
17. Lewis, J. A., Chang, G.-J., Lanciotti, R. S., Kinney, R. M., Mayer, L. W., and Trent, D. W. (1993). Phylogenetic relationships of dengue 2 viruses. Virology 197, 216-224.
18. Leitmeyer, K. C., Vaughn, D. W., Watts, D. M., Salas, R., Villalobos de Chacon, I., Ramos, C., and Rico-Hesse, R. (1999). Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73, 4738-4747.
19. Lok, S. M., Ng, M. L., and Aaskov, J. G. (2001). Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody. J. Med. Virol. 65, 315-323.
20. Novella, I. S., Quer, J., Dominingo, E., and Holland, J. J. (1999). Exponential fitness gains of RNA virus populations are limited by bottleneck effects. J. Virol. 73, 1668-1671.
21. Osatomi, K., and Sumiyoshi, H. (1990). Complete nucleotide sequence of dengue type 3 virus genome RNA. Virology 176, 643-647.
22. Rico-Hesse, R. (1990). Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology 174, 479-493.
23. Rico-Hesse, R., Harrison, L. M., Salas, R. A., Tovar, D., Nisalak, A., Ramos, C., Boshell, J., de Mesa, M. T. R., Nogueira, R. M. R., and da Rosa, A. T. (1997). Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230, 244-251.
24. Rico-Hesse, R., Harrison, L. M., Nisalak, A., Vaughn, D. W., Kalayanarooj, S., Green, S., Rothman, A. L., and Ennis, F. A. (1998). Molecular evolution of dengue type 2 virus in Thailand. Am. J. Trop. Med. Hyg. 58, 96-101.
25. Roehrig, J. T. (1997). Immunochemistry of dengue viruses. In "Dengue and Dengue Haemorrhagic Fever." pp. 199-220. CAB International, New York.
26. Sanchez, I. J., and Ruiz, B. H. (1996). A single nucleotide change in the E protein of dengue virus 2 Mexican strain affects neurovirulence in mice. J. Gen. Virol. 77, 2541-2545.
27. Sardelis, M. R., Edelman, R., Klein, T. A., Innis, B. L., Putnak, J. R., Jones, J. W., and Turell, M. J. (2000). Limited potential for transmission of live dengue virus vaccine candidates by Aedes aegypti and Aedes albopictus. Am. J. Trop. Med. Hyg. 62, 698-701.
28. Serafin, I. L., and Aaskov, J. G. (2001). Identification of epitopes on the envelope protein of dengue 2 and dengue 3 viruses using monoclonal antibodies. Arch. Virol. 146, 2469-2479.
29. Sittisombut, N., Sistayanarain, A., Cardosa, M. J., Salminen, M., Damrongdachakul, S., Kalayanarooj, S., Rojanasuphot, S., Supawadee, J., and Maneekarn, N. (1997). Possible occurrence of a genetic bottleneck in dengue serotype 2 viruses between 1980 and 1987 epidemic seasons in Bangkok, Thailand. Am. J. Trop. Med. Hyg. 57, 100-108.
30. Swofford, D. L. (2000). Phylogenetic Analysis Using Parsimony (*and other methods). Version 4. Sinauer Associates, Sunderland, MA.
31. Trent, D. W., Kinney, R. M., and Huang, C. Y.-H. (1997). Recombinant dengue vaccines. In "Dengue and Dengue Haemorrhagic Fever." pp.379-404. CAB International, New York.
32. Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B., Nimmannitya, S., Suntayakorn, S., Endy, T., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., and Nisalak, A. (2000). Dengue viraemia titer, antibody response pattern and virus serotype correlate with disease severity. J. Infect. Dis. 181, 2-9.
33. Worobey, M., Rambaut, A., and Holmes, E. C. (1999). Widespread intra-serotype recombination in natural populations of dengue virus. Proc. Natl. Acad. Sci. USA 96, 7352-7357.
34. Yang, Z. (1997). PAML: A program package for phylogenetic analysis by maximum likelihood. CABIOS 13, 555-556.
35. Yang, Z., and Bielawski, J. P. (2000). Statistical methods for detecting molecular adaptation. Trends Ecol. Evol. 15, 496-502.
36. Yang, Z., Nielsen, R., Goldman, N., and Pedersen, A. M. K. (2000). Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155, 431-449.
37. Zhou, J., Liu, W. J., Peng, S. W., Sun, X. Y., and Frazer, I. (1999). Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J. Virol. 73, 4972-4982.
38. Zuker, M. (1989). On finding all suboptimal foldings of an RNA molecule. Science 244, 48-52.